News

The agency has acknowledged receipt of the application and will notify the company when the review process is completed. If the FDA grants orphan drug designation, Trevyent would

The deal will focus on the development of basic research including studies on pathogenesis and drug susceptibility of cancer by promoting exchanges among researchers, physicians, and others engaged

The agency lifted the clinical hold after reviewing additional information related to the product candidates’ delivery devices. The company said that the US clinical development of these product

The one-month, prospective, multicentre, open-label Phase II trial enrolled a total of 39 pediatric patients in the US and is designed to characterize safety, procedural factors and clinical

Zykadia is an oral, selective inhibitor of ALK, a gene that can fuse with others to form an abnormal fusion protein that promotes the development and growth of

Under the settlement and license agreement, Horizon has granted Perrigo the non-exclusive right to market a generic diclofenac sodium topical 2% w/w solution in the United States under

Akynzeo is the first approved fixed dose combination oral agent that targets two critical signalling pathways associated with CINV by combining netupitant, an NK1 receptor antagonist, and palonosetron,

The agency approval for plague includes use of the drug for the treatment of pneumonic plague (infection of the lungs), and septicemic plague (infection of the blood). Avelox

"For the first time, we have looked at the Scale clinical trial programme to explore to what degree the benefits of liraglutide 3 mg could be assigned to